Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29446250 | 0.77 | — | — | |
| SCHEMBL28429466 | 0.75 | — | — | |
| SCHEMBL30008059 | 0.75 | — | — | |
| SCHEMBL14574917 | 0.74 | — | — | |
| SCHEMBL29784948 | 0.74 | — | — | |
| SCHEMBL17267904 | 0.73 | ALDH1A1 (0.33) | MEN1ALDH1A1KMT2A | |
| SCHEMBL1662433 | 0.72 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL14784045 | 0.72 | SLC6A2 (0.48) | ALDH1A1KMT2A | |
| SCHEMBL3827602 | 0.71 | SLC6A2 (0.47) | ALDH1A1KMT2A | |
| SCHEMBL29362942 | 0.71 | SLC6A2 (0.47) | ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11673130-B2 | Catalyst system containing a metathesis catalyst and at least one phenolic compound and a process for metathesis of nitrile-butadiene rubber (NBR) using the catalyst system | ARLANXEO DEUTSCHLAND GMBH (DE) | 2023-06-13 | — | — | US | claimed |
| US-20220032279-A1 | CATALYST SYSTEM CONTAINING A METATHESIS CATALYST AND AT LEAST ONE PHENOLIC COMPOUND AND A PROCESS FOR METATHESIS OF NITRILE-BUTADIENE RUBBER (NBR) USING THE CATALYST SYSTEM | ARLANXEO DEUTSCHLAND GMBH (DE) | 2022-02-03 | — | — | US | claimed |
| EP-3713989-B1 | HIGH MOLECULAR WEIGHT POLYOXYETHYLENE WITH DEEP GLASS TEMPERATURE MADE USING THE GRAFTING THROUGH METHOD | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2021-06-30 | — | — | EP | claimed |
| US-10973847-B2 | Core-to-surface polymerization for the synthesis of star polymers and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-04-13 | — | — | US | claimed |
| US-20200377652-A1 | HIGH MOLECULAR WEIGHT POLYOXYALKYLENE WITH LOW GLASS TRANSITION TEMPERATURE, PRODUCED BY THE GRAFTING THROUGH METHOD | COVESTRO DEUTSCHLAND AG (DE) | 2020-12-03 | — | — | US | claimed |
| EP-3087104-B1 | METHOD FOR CONTROLLED METATHESIS DEPOLYMERIZATION OF NATURAL RUBBER FROM NATURAL RUBBER LATEX | MICHELIN & CIE (FR) | 2019-11-13 | — | — | EP | claimed |
| EP-3489278-A1 | HIGH MOLECULAR WEIGHT POLYOXYETHYLENE WITH DEEP GLASS TEMPERATURE MADE USING THE GRAFTING THROUGH METHOD | Covestro Deutschland AG (DE) | 2019-05-29 | — | — | EP | claimed |
| EP-2897992-B1 | FUNCTIONALIZED RESINS OBTAINED VIA OLEFIN METATHESIS | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2017-11-08 | — | — | EP | claimed |
| US-9181360-B2 | Polymers prepared by ring opening / cross metathesis | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-11-10 | — | — | US | claimed |
| US-8669330-B2 | Olefin triblock polymers via ring-opening metathesis polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-03-11 | — | — | US | claimed |
| US-8623962-B2 | Olefin functionalization by metathesis reaction | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-01-07 | — | — | US | claimed |
| US-20130281626-A1 | Polyolefin Compositions and Methods of Production Thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2013-10-24 | — | — | US | claimed |
| US-20130137829-A1 | Functionalization of Vinyl Terminated Polymers by Ring Opening Cross Metathesis | EXXONMOBIL CHEMICAL PATENTS INC. | 2013-05-30 | — | — | US | claimed |
| US-20130041122-A1 | Polymers Prepared By Ring Opening / Cross Metathesis | EXXONMOBIL CHEMICAL PATENTS INC. | 2013-02-14 | — | — | US | claimed |
| US-20130030126-A1 | Olefin Functionalization By Metathesis Reaction | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-01-31 | — | — | US | claimed |
| US-8283419-B2 | Olefin functionalization by metathesis reaction | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-10-09 | — | — | US | claimed |
| US-20120245294-A1 | Olefin Triblock Polymers via Ring-Opening Metathesis Polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2012-09-27 | — | — | US | claimed |
| US-20120245290-A1 | Diblock Copolymers Prepared by Cross Metathesis | EXXONMOBIL CHEMICAL PATENTS INC. | 2012-09-27 | — | — | US | claimed |
| US-20090318647-A1 | Olefin Functionalization By Metathesis Reaction | EXXONMOBIL CHEMICAL PATENTS INC. | 2009-12-24 | — | — | US | claimed |
| US-20080227851-A1 | LAULIMALIDE AND LAULIMALIDE ANALOGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-09-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227851-A1 | LAULIMALIDE AND LAULIMALIDE ANALOGS | SSB, LPXN, LTA | MEN1 326/4885ALDH1A1 3502/4885KMT2A 4481/4885 |
| US-10973847-B2 | Core-to-surface polymerization for the synthesis of star polymers and uses thereof | STARD7, MB, STARD3 | MEN1 4099/4885ALDH1A1 4092/4885KMT2A 3797/4885 |
| US-20130030126-A1 | Olefin Functionalization By Metathesis Reaction | MAX, AP1M1, AP3M1 | MEN1 793/4885ALDH1A1 3705/4885KMT2A 3469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.